Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against…
Scripps Research study illuminates humoral immune response to experimental vaccines. A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against…
Scientists report that they have discovered a way to tweak genes in the body’s immune cells by using electrical fields. For the first time, scientists have found a way to…
Approach could improve understanding of immune system recovery in people treated for HIV infection Findings from an animal study suggest that a non-invasive imaging technique could, with further development, become…
Baseline vitamin D deficiency may be associated with diminished CD4 recovery in HIV-positive patients after initiation of combination antiretroviral therapy (cART), according to findings published in Clinical Nutrition. Although both nutritional status and…
Changes to the immune system remain many years after a hepatitis C infection heals, a new study by researchers at Karolinska Institutet and Hannover Medical School shows. The findings, presented…
While treatments for HIV mean that the disease is no longer largely fatal, the world still lacks a true therapy that can eradicate the virus across a globally – and…
June 10, 2018 – Atlanta, GA – Scientists now report that Treg cells, a type of regulatory lymphocyte, may be protecting babies in the womb from getting infected with the…
Research on broadly neutralizing antibodies (bNAbs) is taking the field of HIV prevention science in new directions, with implications for new prevention interventions and vaccine development. There’s much to know…
Thanks to advances in the development of anti-retroviral therapy (ART), patients with HIV are living longer than ever before. And yet, even in patients on very effective, long-term ART, HIV…
Share the EATG site:
 |  |  |
